These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33762419)

  • 1. Comprehensive Investigation on the Interplay between Feline APOBEC3Z3 Proteins and Feline Immunodeficiency Virus Vif Proteins.
    Kosugi Y; Uriu K; Suzuki N; Yamamoto K; Nagaoka S; Kimura I; Konno Y; Aso H; Willett BJ; Kobayashi T; Koyanagi Y; Ueda MT; Ito J; Sato K
    J Virol; 2021 Jun; 95(13):e0017821. PubMed ID: 33762419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3.
    Yoshikawa R; Takeuchi JS; Yamada E; Nakano Y; Misawa N; Kimura Y; Ren F; Miyazawa T; Koyanagi Y; Sato K
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.
    Yoshikawa R; Izumi T; Yamada E; Nakano Y; Misawa N; Ren F; Carpenter MA; Ikeda T; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
    J Virol; 2016 Jan; 90(1):474-85. PubMed ID: 26491161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feline APOBEC3s, Barriers to Cross-Species Transmission of FIV?
    Zhang Z; Gu Q; Marino D; Lee KL; Kong IK; Häussinger D; Münk C
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29642583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New World feline APOBEC3 potently controls inter-genus lentiviral transmission.
    Konno Y; Nagaoka S; Kimura I; Yamamoto K; Kagawa Y; Kumata R; Aso H; Ueda MT; Nakagawa S; Kobayashi T; Koyanagi Y; Sato K
    Retrovirology; 2018 Apr; 15(1):31. PubMed ID: 29636069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.
    Gu Q; Zhang Z; Cano Ortiz L; Franco AC; Häussinger D; Münk C
    J Virol; 2016 Dec; 90(23):10545-10557. PubMed ID: 27630243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids.
    Zielonka J; Marino D; Hofmann H; Yuhki N; Löchelt M; Münk C
    J Virol; 2010 Jul; 84(14):7312-24. PubMed ID: 20444897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors.
    Zhang Z; Gu Q; Jaguva Vasudevan AA; Hain A; Kloke BP; Hasheminasab S; Mulnaes D; Sato K; Cichutek K; Häussinger D; Bravo IG; Smits SH; Gohlke H; Münk C
    Retrovirology; 2016 Jul; 13(1):46. PubMed ID: 27368163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.
    Troyer RM; Thompson J; Elder JH; VandeWoude S
    J Virol; 2013 Jul; 87(14):7940-51. PubMed ID: 23658451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
    Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of APOBEC3 Lentiviral Restriction Factors in Cats.
    Troyer RM; Malmberg JL; Zheng X; Miller C; MacMillan M; Sprague WS; Wood BA; VandeWoude S
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31500260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-specific differences in the ability of feline lentiviral Vif to degrade feline APOBEC3 proteins.
    Yoshikawa R; Nakano Y; Yamada E; Izumi T; Misawa N; Koyanagi Y; Sato K
    Microbiol Immunol; 2016 Apr; 60(4):272-9. PubMed ID: 26935128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential.
    Ledesma-Feliciano C; Hagen S; Troyer R; Zheng X; Musselman E; Slavkovic Lukic D; Franke AM; Maeda D; Zielonka J; Münk C; Wei G; VandeWoude S; Löchelt M
    Retrovirology; 2018 May; 15(1):38. PubMed ID: 29769087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of
    Cano-Ortiz L; Maletich Junqueira D; Comerlato J; Zani A; Santos Costa C; Michel Roehe P; Franco AC
    Viruses; 2018 May; 10(6):. PubMed ID: 29857485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses.
    Gaba A; Flath B; Chelico L
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.
    Ai Y; Zhu D; Wang C; Su C; Ma J; Ma J; Wang X
    J Virol; 2014 Oct; 88(20):12112-22. PubMed ID: 25122780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restrictions to cross-species transmission of lentiviral infection gleaned from studies of FIV.
    VandeWoude S; Troyer J; Poss M
    Vet Immunol Immunopathol; 2010 Mar; 134(1-2):25-32. PubMed ID: 19896218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins.
    Wang J; Zhang W; Lv M; Zuo T; Kong W; Yu X
    J Virol; 2011 Dec; 85(23):12482-91. PubMed ID: 21957297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity.
    Larue RS; Lengyel J; Jónsson SR; Andrésdóttir V; Harris RS
    J Virol; 2010 Aug; 84(16):8193-201. PubMed ID: 20519393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Productive replication of Vif-chimeric HIV-1 in feline cells.
    Stern MA; Hu C; Saenz DT; Fadel HJ; Sims O; Peretz M; Poeschla EM
    J Virol; 2010 Jul; 84(14):7378-95. PubMed ID: 20463079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.